| |
|
|
|
Harvard Bioscience- Inc.  
|
|
5.15 -0.05 (-0.01%) |
07-13 16:00 |
|
Open: |
5.2 |
Pre close: |
5.2 |
Target:
|
6.17 
|
|
High: |
5.25 |
Low: |
5.05 |
Resistance:
|
5.28
5.55
|
|
Volume: |
52,248 |
Market Cap: |
185M |
Support:
|
4.85
4.04
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.25
|
MACD |
MACD(12,26):
|
0.07 |
|
MA(20): |
5.24 |
Signal(12,26,9): |
0.10 |
|
MA(100): |
5.04  |
Stochastic Oscillator |
%K(14,3):
|
47.62 |
|
MA(250): |
4.09 |
%D(3): |
54.76 |
|
Average Volume(K) |
3-Month: |
18531
|
52-Week |
High:
|
6.15 |
|
10-Days: |
10145 |
Low: |
2.35 |
|
RSI |
RSI(14):
|
49.20 |
Change(%): |
119.1 |
|
Financials, Statistics and Valuation |
|
EPS |
0.070 |
Return on Equity (ttm) |
-5.1 |
Shares Out. (M) |
35.98 |
|
EPS Est. Current Year |
0.130 |
Return on Assets (ttm) |
-2.8 |
Shares Float (M) |
28.36 |
|
EPS Est. Next Year |
0.170 |
PEG Ratio |
2.65 |
% Held by Insiders |
21.90 |
|
EPS Est. Next Quarter |
0.040 |
Qtrly Rev. Growth |
48.0 |
% Held by Institutions |
63.30 |
|
Forward EPS |
0.260 |
Gross Profit (p.s.) |
0.637 |
Shares Short (K) |
295 |
|
Book Value (p.s.) |
2.520 |
EBITDA (p.s.) |
0.042 |
P/E |
73.57 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.04 |
|
Profit Margin |
-4.39 |
Operating Cash Flow
(M) |
2.12 |
P/S |
58638292.00 |
|
Operating Margin |
0.44 |
Levered Free Cash Flow
(M) |
6.82 |
P/CF |
87.41 |
|
|
|
|
|
|
